Accessibility settings

This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (1300) Obstetrics, Gynecology, and Reproductive Medicine (439) Methods and Feasibility Studies (781) Chronic Conditions (572) Microbial genomics and metagenomics (22)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/102121, first published .
Woman with PCOS holding a calendar showing delayed periods, with symptoms listed.

Effects of Lactobacillus crispatus–Containing Probiotics and Metformin on Insulin Resistance, Inflammation, and Gut Microbiome in Polycystic Ovary Syndrome: Protocol for an Open-Label Randomized Controlled Trial

Effects of Lactobacillus crispatus–Containing Probiotics and Metformin on Insulin Resistance, Inflammation, and Gut Microbiome in Polycystic Ovary Syndrome: Protocol for an Open-Label Randomized Controlled Trial

Authors of this article:

Bhuvaneswari H1 Author Orcid Image ;   Suchanda Sahu1 Author Orcid Image ;   Deepthy Balakrishnan2 Author Orcid Image ;   Balamurugan Ramadass1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

There are no citations yet available for this article according to Crossref .